Meritxell Gironella
Research group
- Gastrointestinal and pancreatic oncology Accredited researcher (R3A-CIBER)
Featured publications
-
Micrornas deregulated in intraductal papillary mucinous neoplasm converge on actin cytoskeleton-related pathways that are maintained in pancreatic ductal adenocarcinoma
Authors:Reference: Cancers 2021. -
Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-based Screening for Colorectal Cancer
Authors:Reference: Clinical Gastroenterology And Hepatology 2021. -
MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics
Authors:Reference: Oncogenesis 2020. -
Identification and validation of microRNA profiles in fecal samples for detection of colorectal cancer
Authors:Reference: Gastroenterology 2020. -
Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia
Authors:Reference: Clinical And Translational Gastroenterology 2019. -
Circulating biomarkers for early detection and clinical management of colorectal cancer
Authors:Reference: Molecular Aspects Of Medicine 2019.
Featured Projects
-
Identification and development of novel colorectal cancer biomarkers via state-of-the-art liquid biopsy approaches. Coordinated project. WP7: Prognostic and monitoring biomarkers.
Principal investigator: Ceres Fernandez-Rozadilla, Meritxell Gironella, Ellen Heitzer, David Hughes, Inès Beumer, Rui Neves, Tom Van Wezel, Salvatore Pernagallo, Vivian ViallonFunder: European Comission. Horizon Europe ; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)Code: CE_HE_MSCA_21_DNDuration: 01/11/2022 - 31/10/2026 -
Desarrollo y validación clínica de una firma epigenética para el diagnóstico no invasivo del cáncer de páncreas y las lesiones precursoras - PanCanTEST. Proyectos colaboración-público privada 2021. Ministerio de Ciencia e Innovación
Principal investigator: AMADIX S.L., Meritxell Gironella, NASAS BIOTECH S.L., Fundación Hospital Ramón y Cajal, Parque Científico de MadridFunder: Ministerio de Ciencia e Innovación. Proyectos Colaboración público-privada 2021 (Programa financiador competitivo); CIBEReHD (Sede o evento)Code: CPP2021-008322Duration: 30/06/2022 - 30/06/2025 -
Prospective, multicenter, comparative, parallel study to validate a microRNA-based fecal test for colorectal cancer screening. The miRFec study
Principal investigator: Antoni Castells Garangou, Meritxell GironellaFunder: EIKEN Chemical Co., Ltd. ; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)Duration: 01/04/2021 - 31/03/2024 -
Nuevas estrategias para mejorar el tratamiento y manejo clínico del cáncer de páncreas basadas en la modulación de miRNAs y estudio del impacto sobre la metilación del RNA
Principal investigator: Meritxell GironellaFunder: Instituto de Salud Carlos III (AES 2020) (Programa financiador competitivo); CIBEReHD (Sede o evento)Code: PI20/01696Duration: 01/01/2021 - 31/12/2023